i recently bought some shares in this company. Most likely catalysts for re-rate are likely to be, in no particular order:
1) directors buying
2) benchmarking done comparing market cap of this company versus market cap of other therapeutic companies at the same stage.
3) nearing completion of phase 3 trials (i think this will take another 18 months roughly...I THINK)
Keen to hear others thoughts. As always this is a high risk high reward company.
cheers
Twiggy's Invex Therapeutics | The Imminent Coin Flip, page-139
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.335M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 532 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 8695 | 1 |
View Market Depth
| Last trade - 10.04am 12/08/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable